Global Human Hyperimmune Globulins Supply, Demand and Key Producers, 2023-2029

Page: 112

Published Date: 06 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Human Hyperimmune Globulins market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Human Hyperimmune Globulins production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Hyperimmune Globulins, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Hyperimmune Globulins that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Hyperimmune Globulins total production and demand, 2018-2029, (K Units)
Global Human Hyperimmune Globulins total production value, 2018-2029, (USD Million)
Global Human Hyperimmune Globulins production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Hyperimmune Globulins consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Hyperimmune Globulins domestic production, consumption, key domestic manufacturers and share
Global Human Hyperimmune Globulins production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Hyperimmune Globulins production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Hyperimmune Globulins production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Human Hyperimmune Globulins market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Hyperimmune Globulins market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Human Hyperimmune Globulins Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Hyperimmune Globulins Market, Segmentation by Type
    Hepatitis B Immunoglobulins
    Rabies Immunoglobulins
    Tetanus Immunoglobulins
    Others

Global Human Hyperimmune Globulins Market, Segmentation by Application
    Government Institutions
    Private Sector
    Others

Companies Profiled:
    CSL Behring
    Grifols
    Biotest
    Kedrion
    CBPO
    Emergent (Cangene)
    Kamada
    CNBG
    Hualan Bio
    Shanghai RAAS
    Sichuan Yuanda Shuyang
    ADMA Biologics

Key Questions Answered
1. How big is the global Human Hyperimmune Globulins market?
2. What is the demand of the global Human Hyperimmune Globulins market?
3. What is the year over year growth of the global Human Hyperimmune Globulins market?
4. What is the production and production value of the global Human Hyperimmune Globulins market?
5. Who are the key producers in the global Human Hyperimmune Globulins market?

Table of Contents

1 Supply Summary
    1.1 Human Hyperimmune Globulins Introduction
    1.2 World Human Hyperimmune Globulins Supply & Forecast
        1.2.1 World Human Hyperimmune Globulins Production Value (2018 & 2022 & 2029)
        1.2.2 World Human Hyperimmune Globulins Production (2018-2029)
        1.2.3 World Human Hyperimmune Globulins Pricing Trends (2018-2029)
    1.3 World Human Hyperimmune Globulins Production by Region (Based on Production Site)
        1.3.1 World Human Hyperimmune Globulins Production Value by Region (2018-2029)
        1.3.2 World Human Hyperimmune Globulins Production by Region (2018-2029)
        1.3.3 World Human Hyperimmune Globulins Average Price by Region (2018-2029)
        1.3.4 North America Human Hyperimmune Globulins Production (2018-2029)
        1.3.5 Europe Human Hyperimmune Globulins Production (2018-2029)
        1.3.6 China Human Hyperimmune Globulins Production (2018-2029)
        1.3.7 Japan Human Hyperimmune Globulins Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Hyperimmune Globulins Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Hyperimmune Globulins Major Market Trends

2 Demand Summary
    2.1 World Human Hyperimmune Globulins Demand (2018-2029)
    2.2 World Human Hyperimmune Globulins Consumption by Region
        2.2.1 World Human Hyperimmune Globulins Consumption by Region (2018-2023)
        2.2.2 World Human Hyperimmune Globulins Consumption Forecast by Region (2024-2029)
    2.3 United States Human Hyperimmune Globulins Consumption (2018-2029)
    2.4 China Human Hyperimmune Globulins Consumption (2018-2029)
    2.5 Europe Human Hyperimmune Globulins Consumption (2018-2029)
    2.6 Japan Human Hyperimmune Globulins Consumption (2018-2029)
    2.7 South Korea Human Hyperimmune Globulins Consumption (2018-2029)
    2.8 ASEAN Human Hyperimmune Globulins Consumption (2018-2029)
    2.9 India Human Hyperimmune Globulins Consumption (2018-2029)

3 World Human Hyperimmune Globulins Manufacturers Competitive Analysis
    3.1 World Human Hyperimmune Globulins Production Value by Manufacturer (2018-2023)
    3.2 World Human Hyperimmune Globulins Production by Manufacturer (2018-2023)
    3.3 World Human Hyperimmune Globulins Average Price by Manufacturer (2018-2023)
    3.4 Human Hyperimmune Globulins Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Human Hyperimmune Globulins Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Human Hyperimmune Globulins in 2022
        3.5.3 Global Concentration Ratios (CR8) for Human Hyperimmune Globulins in 2022
    3.6 Human Hyperimmune Globulins Market: Overall Company Footprint Analysis
        3.6.1 Human Hyperimmune Globulins Market: Region Footprint
        3.6.2 Human Hyperimmune Globulins Market: Company Product Type Footprint
        3.6.3 Human Hyperimmune Globulins Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Human Hyperimmune Globulins Production Value Comparison
        4.1.1 United States VS China: Human Hyperimmune Globulins Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Human Hyperimmune Globulins Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Human Hyperimmune Globulins Production Comparison
        4.2.1 United States VS China: Human Hyperimmune Globulins Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Human Hyperimmune Globulins Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Human Hyperimmune Globulins Consumption Comparison
        4.3.1 United States VS China: Human Hyperimmune Globulins Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Human Hyperimmune Globulins Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Human Hyperimmune Globulins Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Human Hyperimmune Globulins Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Human Hyperimmune Globulins Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Human Hyperimmune Globulins Production (2018-2023)
    4.5 China Based Human Hyperimmune Globulins Manufacturers and Market Share
        4.5.1 China Based Human Hyperimmune Globulins Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Human Hyperimmune Globulins Production Value (2018-2023)
        4.5.3 China Based Manufacturers Human Hyperimmune Globulins Production (2018-2023)
    4.6 Rest of World Based Human Hyperimmune Globulins Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Human Hyperimmune Globulins Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Human Hyperimmune Globulins Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Human Hyperimmune Globulins Production (2018-2023)

5 Market Analysis by Type
    5.1 World Human Hyperimmune Globulins Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Hepatitis B Immunoglobulins
        5.2.2 Rabies Immunoglobulins
        5.2.3 Tetanus Immunoglobulins
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Human Hyperimmune Globulins Production by Type (2018-2029)
        5.3.2 World Human Hyperimmune Globulins Production Value by Type (2018-2029)
        5.3.3 World Human Hyperimmune Globulins Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Human Hyperimmune Globulins Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Government Institutions
        6.2.2 Private Sector
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Human Hyperimmune Globulins Production by Application (2018-2029)
        6.3.2 World Human Hyperimmune Globulins Production Value by Application (2018-2029)
        6.3.3 World Human Hyperimmune Globulins Average Price by Application (2018-2029)

7 Company Profiles
    7.1 CSL Behring
        7.1.1 CSL Behring Details
        7.1.2 CSL Behring Major Business
        7.1.3 CSL Behring Human Hyperimmune Globulins Product and Services
        7.1.4 CSL Behring Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 CSL Behring Recent Developments/Updates
        7.1.6 CSL Behring Competitive Strengths & Weaknesses
    7.2 Grifols
        7.2.1 Grifols Details
        7.2.2 Grifols Major Business
        7.2.3 Grifols Human Hyperimmune Globulins Product and Services
        7.2.4 Grifols Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Grifols Recent Developments/Updates
        7.2.6 Grifols Competitive Strengths & Weaknesses
    7.3 Biotest
        7.3.1 Biotest Details
        7.3.2 Biotest Major Business
        7.3.3 Biotest Human Hyperimmune Globulins Product and Services
        7.3.4 Biotest Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Biotest Recent Developments/Updates
        7.3.6 Biotest Competitive Strengths & Weaknesses
    7.4 Kedrion
        7.4.1 Kedrion Details
        7.4.2 Kedrion Major Business
        7.4.3 Kedrion Human Hyperimmune Globulins Product and Services
        7.4.4 Kedrion Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Kedrion Recent Developments/Updates
        7.4.6 Kedrion Competitive Strengths & Weaknesses
    7.5 CBPO
        7.5.1 CBPO Details
        7.5.2 CBPO Major Business
        7.5.3 CBPO Human Hyperimmune Globulins Product and Services
        7.5.4 CBPO Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 CBPO Recent Developments/Updates
        7.5.6 CBPO Competitive Strengths & Weaknesses
    7.6 Emergent (Cangene)
        7.6.1 Emergent (Cangene) Details
        7.6.2 Emergent (Cangene) Major Business
        7.6.3 Emergent (Cangene) Human Hyperimmune Globulins Product and Services
        7.6.4 Emergent (Cangene) Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Emergent (Cangene) Recent Developments/Updates
        7.6.6 Emergent (Cangene) Competitive Strengths & Weaknesses
    7.7 Kamada
        7.7.1 Kamada Details
        7.7.2 Kamada Major Business
        7.7.3 Kamada Human Hyperimmune Globulins Product and Services
        7.7.4 Kamada Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Kamada Recent Developments/Updates
        7.7.6 Kamada Competitive Strengths & Weaknesses
    7.8 CNBG
        7.8.1 CNBG Details
        7.8.2 CNBG Major Business
        7.8.3 CNBG Human Hyperimmune Globulins Product and Services
        7.8.4 CNBG Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 CNBG Recent Developments/Updates
        7.8.6 CNBG Competitive Strengths & Weaknesses
    7.9 Hualan Bio
        7.9.1 Hualan Bio Details
        7.9.2 Hualan Bio Major Business
        7.9.3 Hualan Bio Human Hyperimmune Globulins Product and Services
        7.9.4 Hualan Bio Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Hualan Bio Recent Developments/Updates
        7.9.6 Hualan Bio Competitive Strengths & Weaknesses
    7.10 Shanghai RAAS
        7.10.1 Shanghai RAAS Details
        7.10.2 Shanghai RAAS Major Business
        7.10.3 Shanghai RAAS Human Hyperimmune Globulins Product and Services
        7.10.4 Shanghai RAAS Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Shanghai RAAS Recent Developments/Updates
        7.10.6 Shanghai RAAS Competitive Strengths & Weaknesses
    7.11 Sichuan Yuanda Shuyang
        7.11.1 Sichuan Yuanda Shuyang Details
        7.11.2 Sichuan Yuanda Shuyang Major Business
        7.11.3 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product and Services
        7.11.4 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
        7.11.6 Sichuan Yuanda Shuyang Competitive Strengths & Weaknesses
    7.12 ADMA Biologics
        7.12.1 ADMA Biologics Details
        7.12.2 ADMA Biologics Major Business
        7.12.3 ADMA Biologics Human Hyperimmune Globulins Product and Services
        7.12.4 ADMA Biologics Human Hyperimmune Globulins Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 ADMA Biologics Recent Developments/Updates
        7.12.6 ADMA Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Hyperimmune Globulins Industry Chain
    8.2 Human Hyperimmune Globulins Upstream Analysis
        8.2.1 Human Hyperimmune Globulins Core Raw Materials
        8.2.2 Main Manufacturers of Human Hyperimmune Globulins Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Human Hyperimmune Globulins Production Mode
    8.6 Human Hyperimmune Globulins Procurement Model
    8.7 Human Hyperimmune Globulins Industry Sales Model and Sales Channels
        8.7.1 Human Hyperimmune Globulins Sales Model
        8.7.2 Human Hyperimmune Globulins Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Human Hyperimmune Globulins Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Human Hyperimmune Globulins Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Human Hyperimmune Globulins Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Human Hyperimmune Globulins Production Value Market Share by Region (2018-2023)
    Table 5. World Human Hyperimmune Globulins Production Value Market Share by Region (2024-2029)
    Table 6. World Human Hyperimmune Globulins Production by Region (2018-2023) & (K Units)
    Table 7. World Human Hyperimmune Globulins Production by Region (2024-2029) & (K Units)
    Table 8. World Human Hyperimmune Globulins Production Market Share by Region (2018-2023)
    Table 9. World Human Hyperimmune Globulins Production Market Share by Region (2024-2029)
    Table 10. World Human Hyperimmune Globulins Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Human Hyperimmune Globulins Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Human Hyperimmune Globulins Major Market Trends
    Table 13. World Human Hyperimmune Globulins Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Human Hyperimmune Globulins Consumption by Region (2018-2023) & (K Units)
    Table 15. World Human Hyperimmune Globulins Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Human Hyperimmune Globulins Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Human Hyperimmune Globulins Producers in 2022
    Table 18. World Human Hyperimmune Globulins Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Human Hyperimmune Globulins Producers in 2022
    Table 20. World Human Hyperimmune Globulins Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Human Hyperimmune Globulins Company Evaluation Quadrant
    Table 22. World Human Hyperimmune Globulins Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Human Hyperimmune Globulins Production Site of Key Manufacturer
    Table 24. Human Hyperimmune Globulins Market: Company Product Type Footprint
    Table 25. Human Hyperimmune Globulins Market: Company Product Application Footprint
    Table 26. Human Hyperimmune Globulins Competitive Factors
    Table 27. Human Hyperimmune Globulins New Entrant and Capacity Expansion Plans
    Table 28. Human Hyperimmune Globulins Mergers & Acquisitions Activity
    Table 29. United States VS China Human Hyperimmune Globulins Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Human Hyperimmune Globulins Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Human Hyperimmune Globulins Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Human Hyperimmune Globulins Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Human Hyperimmune Globulins Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Human Hyperimmune Globulins Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Human Hyperimmune Globulins Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Human Hyperimmune Globulins Production Market Share (2018-2023)
    Table 37. China Based Human Hyperimmune Globulins Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Human Hyperimmune Globulins Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Human Hyperimmune Globulins Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Human Hyperimmune Globulins Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Human Hyperimmune Globulins Production Market Share (2018-2023)
    Table 42. Rest of World Based Human Hyperimmune Globulins Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Human Hyperimmune Globulins Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Human Hyperimmune Globulins Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Human Hyperimmune Globulins Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Human Hyperimmune Globulins Production Market Share (2018-2023)
    Table 47. World Human Hyperimmune Globulins Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Human Hyperimmune Globulins Production by Type (2018-2023) & (K Units)
    Table 49. World Human Hyperimmune Globulins Production by Type (2024-2029) & (K Units)
    Table 50. World Human Hyperimmune Globulins Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Human Hyperimmune Globulins Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Human Hyperimmune Globulins Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Human Hyperimmune Globulins Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Human Hyperimmune Globulins Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Human Hyperimmune Globulins Production by Application (2018-2023) & (K Units)
    Table 56. World Human Hyperimmune Globulins Production by Application (2024-2029) & (K Units)
    Table 57. World Human Hyperimmune Globulins Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Human Hyperimmune Globulins Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Human Hyperimmune Globulins Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Human Hyperimmune Globulins Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. CSL Behring Basic Information, Manufacturing Base and Competitors
    Table 62. CSL Behring Major Business
    Table 63. CSL Behring Human Hyperimmune Globulins Product and Services
    Table 64. CSL Behring Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. CSL Behring Recent Developments/Updates
    Table 66. CSL Behring Competitive Strengths & Weaknesses
    Table 67. Grifols Basic Information, Manufacturing Base and Competitors
    Table 68. Grifols Major Business
    Table 69. Grifols Human Hyperimmune Globulins Product and Services
    Table 70. Grifols Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Grifols Recent Developments/Updates
    Table 72. Grifols Competitive Strengths & Weaknesses
    Table 73. Biotest Basic Information, Manufacturing Base and Competitors
    Table 74. Biotest Major Business
    Table 75. Biotest Human Hyperimmune Globulins Product and Services
    Table 76. Biotest Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Biotest Recent Developments/Updates
    Table 78. Biotest Competitive Strengths & Weaknesses
    Table 79. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 80. Kedrion Major Business
    Table 81. Kedrion Human Hyperimmune Globulins Product and Services
    Table 82. Kedrion Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Kedrion Recent Developments/Updates
    Table 84. Kedrion Competitive Strengths & Weaknesses
    Table 85. CBPO Basic Information, Manufacturing Base and Competitors
    Table 86. CBPO Major Business
    Table 87. CBPO Human Hyperimmune Globulins Product and Services
    Table 88. CBPO Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. CBPO Recent Developments/Updates
    Table 90. CBPO Competitive Strengths & Weaknesses
    Table 91. Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
    Table 92. Emergent (Cangene) Major Business
    Table 93. Emergent (Cangene) Human Hyperimmune Globulins Product and Services
    Table 94. Emergent (Cangene) Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Emergent (Cangene) Recent Developments/Updates
    Table 96. Emergent (Cangene) Competitive Strengths & Weaknesses
    Table 97. Kamada Basic Information, Manufacturing Base and Competitors
    Table 98. Kamada Major Business
    Table 99. Kamada Human Hyperimmune Globulins Product and Services
    Table 100. Kamada Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Kamada Recent Developments/Updates
    Table 102. Kamada Competitive Strengths & Weaknesses
    Table 103. CNBG Basic Information, Manufacturing Base and Competitors
    Table 104. CNBG Major Business
    Table 105. CNBG Human Hyperimmune Globulins Product and Services
    Table 106. CNBG Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. CNBG Recent Developments/Updates
    Table 108. CNBG Competitive Strengths & Weaknesses
    Table 109. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 110. Hualan Bio Major Business
    Table 111. Hualan Bio Human Hyperimmune Globulins Product and Services
    Table 112. Hualan Bio Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Hualan Bio Recent Developments/Updates
    Table 114. Hualan Bio Competitive Strengths & Weaknesses
    Table 115. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 116. Shanghai RAAS Major Business
    Table 117. Shanghai RAAS Human Hyperimmune Globulins Product and Services
    Table 118. Shanghai RAAS Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Shanghai RAAS Recent Developments/Updates
    Table 120. Shanghai RAAS Competitive Strengths & Weaknesses
    Table 121. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
    Table 122. Sichuan Yuanda Shuyang Major Business
    Table 123. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product and Services
    Table 124. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Sichuan Yuanda Shuyang Recent Developments/Updates
    Table 126. ADMA Biologics Basic Information, Manufacturing Base and Competitors
    Table 127. ADMA Biologics Major Business
    Table 128. ADMA Biologics Human Hyperimmune Globulins Product and Services
    Table 129. ADMA Biologics Human Hyperimmune Globulins Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Human Hyperimmune Globulins Upstream (Raw Materials)
    Table 131. Human Hyperimmune Globulins Typical Customers
    Table 132. Human Hyperimmune Globulins Typical Distributors
List of Figure
    Figure 1. Human Hyperimmune Globulins Picture
    Figure 2. World Human Hyperimmune Globulins Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Human Hyperimmune Globulins Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Human Hyperimmune Globulins Production (2018-2029) & (K Units)
    Figure 5. World Human Hyperimmune Globulins Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Human Hyperimmune Globulins Production Value Market Share by Region (2018-2029)
    Figure 7. World Human Hyperimmune Globulins Production Market Share by Region (2018-2029)
    Figure 8. North America Human Hyperimmune Globulins Production (2018-2029) & (K Units)
    Figure 9. Europe Human Hyperimmune Globulins Production (2018-2029) & (K Units)
    Figure 10. China Human Hyperimmune Globulins Production (2018-2029) & (K Units)
    Figure 11. Japan Human Hyperimmune Globulins Production (2018-2029) & (K Units)
    Figure 12. Human Hyperimmune Globulins Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Human Hyperimmune Globulins Consumption (2018-2029) & (K Units)
    Figure 15. World Human Hyperimmune Globulins Consumption Market Share by Region (2018-2029)
    Figure 16. United States Human Hyperimmune Globulins Consumption (2018-2029) & (K Units)
    Figure 17. China Human Hyperimmune Globulins Consumption (2018-2029) & (K Units)
    Figure 18. Europe Human Hyperimmune Globulins Consumption (2018-2029) & (K Units)
    Figure 19. Japan Human Hyperimmune Globulins Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Human Hyperimmune Globulins Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Human Hyperimmune Globulins Consumption (2018-2029) & (K Units)
    Figure 22. India Human Hyperimmune Globulins Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Human Hyperimmune Globulins by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Hyperimmune Globulins Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Hyperimmune Globulins Markets in 2022
    Figure 26. United States VS China: Human Hyperimmune Globulins Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Human Hyperimmune Globulins Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Human Hyperimmune Globulins Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Human Hyperimmune Globulins Production Market Share 2022
    Figure 30. China Based Manufacturers Human Hyperimmune Globulins Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Human Hyperimmune Globulins Production Market Share 2022
    Figure 32. World Human Hyperimmune Globulins Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Human Hyperimmune Globulins Production Value Market Share by Type in 2022
    Figure 34. Hepatitis B Immunoglobulins
    Figure 35. Rabies Immunoglobulins
    Figure 36. Tetanus Immunoglobulins
    Figure 37. Others
    Figure 38. World Human Hyperimmune Globulins Production Market Share by Type (2018-2029)
    Figure 39. World Human Hyperimmune Globulins Production Value Market Share by Type (2018-2029)
    Figure 40. World Human Hyperimmune Globulins Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Human Hyperimmune Globulins Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Human Hyperimmune Globulins Production Value Market Share by Application in 2022
    Figure 43. Government Institutions
    Figure 44. Private Sector
    Figure 45. Others
    Figure 46. World Human Hyperimmune Globulins Production Market Share by Application (2018-2029)
    Figure 47. World Human Hyperimmune Globulins Production Value Market Share by Application (2018-2029)
    Figure 48. World Human Hyperimmune Globulins Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Human Hyperimmune Globulins Industry Chain
    Figure 50. Human Hyperimmune Globulins Procurement Model
    Figure 51. Human Hyperimmune Globulins Sales Model
    Figure 52. Human Hyperimmune Globulins Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics

Related Reports

Global Human Hyperimmune Globulins Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Human Hyperimmune Globulins Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 29 Jan 2021

date Pharma & Healthcare

The Human Hyperimmune Globulins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Human Hyperimmune Globulins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Human Hyperimmune Globulins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 08 Jan 2022

date Pharma & Healthcare

Global Human Hyperimmune Globulins Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Human Hyperimmune Globulins Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Hyperimmune Globulins market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Human Hyperimmune Globulins Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Human Hyperimmune Globulins Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 14 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Human Hyperimmune Globulins market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

human hyperimmune globulins

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>